Acetylcholine – A neurotransmitter involved in neuromuscular transmission, parasympathetic control, and central modulation (cholinergic).
Addiction – A chronic, relapsing disorder characterized by compulsive drug seeking and use despite harmful consequences.
Adenosine – A neuromodulator that promotes sleep and suppresses arousal.
Agonist – A substance that activates a receptor to produce a biological response.
Alcohol Dependence – A condition involving tolerance, withdrawal symptoms, and compulsive use of alcohol.
Antagonist – A substance that blocks or dampens a biological response by binding to a receptor.
Anhedonia – Loss of interest or pleasure in activities once found enjoyable, commonly seen in depression.
Anxiety Disorder – A mental health disorder characterized by chronic worry, restlessness, and physical symptoms like muscle tension and fatigue.
Blood-Brain Barrier – A selective barrier that protects the brain from potentially harmful substances in the bloodstream.
CNS Depressants – Drugs like alcohol, benzodiazepines (e.g., Xanax), that slow down brain activity; withdrawal may lead to seizures or agitation.
Cognition – Mental processes like thinking, learning, memory, and attention.
Conditioning – A learning process in which a behavior becomes more likely due to association with a stimulus (important in addiction).
Cortisol – A stress hormone that may be elevated in mood disorders and linked to inflammation.
Dependence – A state where neurons adapt to drug presence and function abnormally without it.
Dopamine – A neurotransmitter involved in reward, motivation, and motor function (dopaminergic).
Dysphoric Mood – A general feeling of unease or dissatisfaction, common in mood disorders.
Endorphins – Natural opioid-like neurotransmitters that reduce pain and create a sense of well-being.
Excitatory Neurotransmitter – A neurotransmitter (e.g., glutamate) that increases the likelihood of a neuron firing.
GABA (Gamma-Aminobutyric Acid) – The main inhibitory neurotransmitter in the brain, calming neural activity (GABAergic).
Glutamate – The primary excitatory neurotransmitter involved in learning and memory (glutamatergic).
Histamine – A neurotransmitter that promotes wakefulness and alertness (histaminergic).
HPA Axis – Hypothalamic-pituitary-adrenal axis; plays a key role in the stress response and is implicated in depression.
Lethal Dose (LD50) – The amount of a substance required to kill 50% of a test population.
Mesolimbic Pathway – A dopaminergic pathway in the brain associated with reward and pleasure.
Mesocortical Pathway – Dopaminergic pathway involved in cognition, emotion, and executive function.
Mood Disorder – A category of mental health disorders that includes major depressive disorder and bipolar disorder.
Neurotransmitter – Chemicals that transmit signals across synapses between neurons.
Nigrostriatal Pathway – Dopamine pathway that regulates movement; degeneration is linked to Parkinson’s disease.
Norepinephrine – A neurotransmitter involved in arousal, stress, and sympathetic nervous system responses (noradrenergic).
Opioids – Substances (natural or synthetic) that bind to opioid receptors, often used for pain relief; highly addictive.
Pathway (Neural) – A series of connected neurons that control a specific function (e.g., reward, mood).
Potency – A measure of drug strength or effectiveness.
Prediction Error – The difference between expected and actual outcomes, used by the brain to learn and adjust behavior.
Psychostimulants – Drugs like methamphetamine or cocaine that increase activity in the brain.
Reuptake Inhibitor – A substance that blocks the reabsorption of neurotransmitters, increasing their availability in the synaptic cleft.
Reward Prediction Error (RPE) – A process where unexpected rewards cause a dopamine spike, reinforcing future behaviors.
Route of Administration – How a drug is taken (e.g., oral, IV, inhaled, sublingual).
Serotonin – A neurotransmitter associated with mood, sleep, and appetite regulation (serotonergic).
Stimulants – Drugs that increase neural activity and energy (e.g., caffeine, cocaine, meth).
Tolerance – The need to take more of a substance to achieve the same effect.
Tuberoinfundibular Pathway – A dopamine pathway that regulates prolactin secretion.
Withdrawal – A set of symptoms that occur when stopping or reducing intake of an addictive substance. Symptoms often include the opposite of the drug’s effects (e.g., irritability after stopping alcohol).